FTY720 enhances the activation-induced apoptosis of donor T cells and modulates graft-versus-host disease

European Journal of Immunology

Volumn 37, Issue 1, 2007, Pages 271-281

  Hashimoto, Daigo ^a,b   Asakura, Shoji ^a   Matsuoka, Ken Ichi ^a   Sakoda, Yukimi ^a   Koyama, Motoko ^a   Aoyama, Kazutoshi ^a   Tanimoto, Mitsune ^a   Takanori, Teshima ^b  

^a OKAYAMA UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY HOSPITAL   (Japan)

Author keywords

Animal models; Apoptosis; Transplantation

Indexed keywords

CASPASE; FINGOLIMOD;

ADOPTIVE TRANSFER; ALLOGENIC BONE MARROW TRANSPLANTATION; ALLOIMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL CULTURE; CELL ISOLATION; CONTROLLED STUDY; DISEASE SEVERITY; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; IMMUNOMODULATION; IN VIVO STUDY; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, ORAL; ADOPTIVE TRANSFER; ANIMALS; APOPTOSIS; BONE MARROW TRANSPLANTATION; CELLS, CULTURED; FEMALE; GRAFT VS HOST DISEASE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DEPLETION; LYMPHOPENIA; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; PROPYLENE GLYCOLS; SPHINGOSINE; T-LYMPHOCYTES;

EID: 33846368457     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200636123     Document Type: Article

References (63)

1. Shlomchik, W. D., Couzens, M. S., Tang, C. B., McNiff, J., Robert, M. E., Liu, J., Shlomchik, M. J. and Emerson, S. G., Prevention of graft versus host disease by inactivation of host antigen-presenting cells. Science 1999. 285: 412-415.
2. Teshima, T., Ordemann, R., Reddy, P., Gagin, S., Liu, C., Cooke, K. R. and Ferrara, J. L., Acute graft-versus-host disease does not require alloantigen expression on host epithelium. Nat. Med. 2002. 8: 575-581.
3. Korngold, R. and Sprent, J., Negative selection of T cells causing lethal graft-versus-host disease across minor histocompatibility barriers. Role of the H-2 complex. J. Exp. Med. 1980. 151: 1114-1124.
4. Hill, G. R. and Ferrara, J. L., The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: Rationale for the use of cytokine shields in allogeneic bone marrow transplantation. Blood 2000. 95: 2754-2759.
5. Van Parijs, L. and Abbas, A. K., Homeostasis and self-tolerance in the immune system: Turning lymphocytes off. Science 1998. 280: 243-248.
6. Russell, J. H., Activation-induced death of mature T cells in the regulation of immune responses. Curr. Opin. Immunol. 1995. 7: 382-388.
7. Dey, B. R., Yang, Y. G., Szot, G. L., Pearson, D. A. and Sykes, M., Interleukin-12 inhibits graft-versus-host disease through a Fas-mediated mechanism associated with alterations in donor T-cell activation and expansion. Blood 1998. 91: 3315-3322.
8. Dey, B., Yang, Y. G., Preffer, F., Shimizu, A., Swenson, K., Dombkowski, D. and Sykes, M., The fate of donor T-cell receptor transgenic T cells with known host antigen specificity in a graft-versus-host disease model. Transplantation 1999. 68: 141-149.
9. Yang, Y. G., Dey, B. R., Sergio, J. J., Pearson, D. A. and Sykes, M., Donor-derived interferon gamma is required for inhibition of acute graft-versus-host disease by interleukin 12. J. Clin. Invest. 1998. 102: 2126-2135.
10. Iezzi, G., Karjalainen, K. and Lanzavecchia, A., The duration of antigenic stimulation determines the fate of naive and effector T cells. Immunity1998. 8: 89-95.
11. + T cells responding to a bacterial superantigen. J. Immunol. 1995. 154: 4302-4308.
12. Lenardo, M., Chan, K. M., Hornung, F., McFarland, H., Siegel, R., Wang, J. and Zheng, L., Mature T lymphocyte apoptosis - immune regulation in a dynamic and unpredictable antigenic environment. Annu. Rev. Immunol. 1999-17: 221-253.
13. Jelley-Gibbs, D. M., Dibble, J. P., Filipson, S., Haynes, L., Kemp, R. A. and Swain, S. L., Repeated stimulation of CD4 effector T cells can limit their protective function. J. Exp. Med. 2005. 201: 1101-1112.
14. Fujita, T., Hirose, R., Yoneta, M., Sasaki, S., Inoue, K., Kiuchi, M., Hirase, S. et al., Potent immunosuppressants, 2-alkyl-2-aminopropane-1,3-diols. J. Med. Chem. 1996. 39: 4451-4459.
15. Brinkmann, V., Davis, M. D., Heise, C. E., Albert, R., Cottens, S., Hof, R., Bruns, C. et al., The immune modulator FTY720 targets sphingosine I- phosphate receptors. J. Biol. Chem. 2002. 277: 21453-21457.
16. Mandala, S., Hajdu, R., Bergstrom, J., Quackenbush, E., Xie, J., Milligan, J., Thornton, R. et al., Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists. Science 2002. 296: 346-349.
17. Matloubian, M., Lo, C. G., Cinamon, G., Lesneski, M. J., Xu, Y., Brinkmann, V., Allende, M. L. et al., Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on SIP receptor 1. Nature 2004. 427: 355-360.
18. Chiba, K., Yanagawa, Y., Masubuchi, Y., Kataoka, H., Kawaguchi, T., Ohtsuki, M. and Hoshino, Y., FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. I. FTY720 selectively decreases the number of circulating mature lymphocytes by acceleration of lymphocyte homing. J. Immunol. 1998. 160: 5037-5044.
19. Yanagawa, Y., Sugahara, K., Kataoka, H., Kawaguchi, T., Masubuchi, Y. and Chiba, K., FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. IL FTY720 prolongs skin allograft survival by decreasing T cell infiltration into grafts but not cytokine production in vivo. J. Immunol. 1998. 160: 5493-5499.
20. Troncoso, P., Stepkowski, S. M., Wang, M. E., Qu, X., Chueh, S. C., Clark, J. and Kahan, B. D., Prophylaxis of acute renal allograft rejection using FTY720 in combination with subtherapeutic doses of cyclosporine. Transplantation 1999. 67: 145-151.
21. Kim, Y. M., Sachs, T., Asavaroengchai, W., Bronson, R. and Sykes, M., Graft-versus-host disease can be separated from graft-versus-lymphoma effects by control of lymphocyte trafficking with FTY720. J. Clin. Invest. 2003. 111: 659-669.
22. Hill, G. R., Cooke, K. R., Teshima, T., Crawford, J. M., Keith, J. C., Jr., Brinson, Y. S., Bungard, D. and Ferrara, J. L., Interleukin-11 promotes T cell polarization and prevents acute graft-versus-host disease after allogeneic bone marrow transplantation. J. Clin. Invest. 1998. 102: 115-123.
23. Teshima, T. and Ferrara, J. L., Understanding the alloresponse: New approaches to graft-versus-host disease prevention. Semin. Hematol. 2002. 39: 15-22.
24. + T cells. J. Immunol. 2003. 170: 3662-3670.
25. Kataoka, H., Ohtsuki, M., Shimano, K., Mochizuki, S., Oshita, K., Murata, M., Sugahara, K. et al., Immunosuppressive activity of FTY720, sphingosine 1-phosphate receptor agonist: IL Effect of FTY720 and FTY720-phosphate on host-versus-graft and graft-versus-host reaction in mice. Transplant Proc. 2005. 37: 107-109.
26. Morris, M. A., Gibb, D. R., Picard, F., Brinkmann, V., Straume, M. and Ley, K., Transient T cell accumulation in lymph nodes and sustained lymphopenia in mice treated with FTY720. Eur. J. Immunol. 2005. 35: 3570-3580.
27. + T cell activation through caspase-8-dependent NF-kappa B activation. J. Immunol. 2005. 174: 5270-5278.
28. Suzuki, S., Enosawa, S., Kakefuda, T., Shinomiya, T., Amari, M., Naoe, S., Hoshino, Y. and Chiba, K., A novel immunosuppressant, FTY720, with a unique mechanism of action, induces long-term graft acceptance in rat and dog allotransplantation. Transplantation 1996. 61: 200-205.
29. Brinkmann, V., Pinschewer, D. D., Feng, L. and Chen, S., FTY720: Altered lymphocyte traffic results in allograft protection. Transplantation 2001. 72: 764-769.
30. Kahan, B. D., individuality: The barrier to optimal immunosuppression. Nat. Rev. Immunol. 2003. 3: 831-838.
31. Lee, R. S., Kuhr, C. S., Sale, G. E., Zellmer, E., Hogan, W. J., Storb, R. and Little, M. T., FTY720 does not abrogate acute graft-versus-host disease in the dog leukocyte antigen-nonidentical unrelated canine model. Transplantation 2003. 76: 1155-1158.
32. Pinschewer, D. D., Ochsenbein, A. F., Odermatt, B., Brinkmann, V., Hengartner, H. and Zinkernagel, R. M., FTY720 immunosuppression impairs effector T cell peripheral homing without affecting induction, expansion, and memory. J. Immunol. 2000. 164: 5761-5770.
33. Cyster, J. G., Chemokines, sphingosine-1-phosphate, and cell migration in secondary lymphoid organs. Annu. Rev. Immunol. 2005. 23: 127-159.
34. Rosen, H. and Goetzl, E. J., Sphingosine 1-phosphate and its receptors: An autocrine and paracrine network. Nat. Rev. Immunol. 2005. 5: 560-570.
35. Halin, C., Scimone, M. L., Bonasio, R., Gauguet, J. M., Mempel, T. R., Quackenbush, E., Proia, R. L. et al., The S1P-analog FTY720 differentially modulates T-cell homing via HEV T-cell-expressed S1P1 amplifies integrin activation in peripheral lymph nodes but not in Peyer patches. Blood 2005. 106: 1314-1322.
36. Lo, C. G., Xu, Y., Proia, R. L. and Cyster, J. G., Cyclical modulation of sphingosine-1-phosphate receptor 1 surface expression during lymphocyte recirculation and relationship to lymphoid organ transit. J. Exp. Med. 2005. 201: 291-301.
37. Duffner, U. A., Maeda, Y., Cooke, K. R., Reddy, P., Ordemann, R., Liu, C., Ferrara, J. L. and Teshima, T., Host dendritic cells alone are sufficient to initiate acute graft-versus-host disease. J. Immunol. 2004. 172: 7393-7398.
38. Michalek, J., Collins, R. H., Hill, B. J., Brenchley, J. M. and Douek, D. C., Identification and monitoring of graft-versus-host specific T-cell clone in stem cell transplantation. Lancet 2003. 361: 1183-1185.
39. + T cell activity. J. Immunol. 1993. 150: 197-205.
40. Sykes, M., Pearson, D. A. and Szot, G. L., IL-2-induced GVHD protection is not inhibited by cyclosporine and is maximal when IL-2 is given over a 25 h period beginning on the day following bone marrow transplantation. Bone Marrow Transplant 1995. 15: 395-399.
41. Reddy, P., Teshima, T., Kukuruga, M., Ordemann, R., Liu, C., Lowler, K. and Ferrara, J. L., Interleukin-18 regulates acute graft-versus-host disease by enhancing Fas-mediated donor T cell apoptosis. J. Exp. Med. 2001. 194: 1433-1440.
42. Drobyski, W. R., Komorowski, R., Logan, B. and Gendelman, M., Role of the passive apoptotic pathway in graft-versus-host disease. J. Immunol. 2002. 169: 1626-1633.
43. Habicht, A., Clarkson, M. R., Yang, J., Henderson, J., Brinkmann, V., Fernandes, S., Jurewicz, M. et al., Novel insights into the mechanism of action of FTY720 in a transgenic model of allograft rejection: Implications for therapy of chronic rejection. J. Immunol. 2006. 176: 36-42.
44. + T cell-mediated graft-versus-host disease: Effects of conditioning. Biol. Blood Marrow Transplant. 2000. 6: 604-612.
45. Hartwig, U. F., Robbers, M., Wickenhauser, C. and Huber, C., Murine acute graft-versus-host disease can be prevented by depletion of alloreactive T lymphocytes using activation-induced cell death. Blood 2002. 99: 3041-3049.
46. Brochu, S., Rioux-Masse, B., Roy, J., Roy, D. C. and Perreault, C., Massive activation-induced cell death of alloreactive T cells with apoptosis of bystander postthymic T cells prevents immune reconstitution in mice with graft-versus-host disease. Blood 1999. 94: 390-400.
47. Godfrey, W. R., Krampf, M. R., Taylor, P. A. and Blazar, B. R., EX vivo depletion of alloreactive cells based on CFSE dye dilution, activation antigen selection, and dendritic cell stimulation. Blood 2004. 103: 1158-1165.
48. Fehse, B., Frerk, 0., Goldmann, M., Bulduk, M. and Zander, A. R., Efficient depletion of alloreactive donor T lymphocytes based on expression of two activation-induced antigens (CD25 and CD69). Br. J. Haematol. 2000. 109: 644-651.
49. van Dijk, A. M., Kessler, F. L., Stadhouders-Keet, S. A., Verdonck, L. F., de Gast, G. C. and Otten, H. G., Selective depletion of major and minor histocompatibility antigen reactive T cells: Towards prevention of acute graft-versus-host disease. Br. J. Haematol. 1999. 107: 169-175.
50. Blanco, B., Perez-Simon, J. A., Sanchez-Abarca, L. L, Carvajal-Vergara, X., Mateos, J., Vidriales, B., Lopez-Holgado, N. et al., Bortezomib induces selective depletion of alloreactive T lymphocytes and decreases the production of Thl cytokines. Blood 2006. 107: 3575-3583.
51. + T-cell subsets after experimental allogeneic bone marrow transplantation. Blood 2004. 104: 3393-3399.
52. + T cells. Blood 2005. 105: 2206-2213.
53. Huang, C. C., Lu, Y. F., Wen, S. N., Hsieh, W. C., Lin, Y. C., Liu, M. R., Chiang, E. et al., Anovel apoptosis-inducing anti-PSGL-1 antibody for T cell-mediated diseases. Eur. J. Immunol. 2005. 35: 2239-2249.
54. Yu, X. Z., Albert, M. H., Martin, P. J. and Anasetti, C., CD28 ligation induces transplantation tolerance by IFN-gamma-dependent depletion of T cells that recognize alloantigens. J. Clin. Invest. 2004. 113: 1624-1630.
55. Carpenter, P. A., Lowder, J., Johnston, L., Frangoul, H., Khoury, H., Parker, P., Jerome, K. R. et al., A phase II multicenter study of visilizumab, humanized anti-CD3 antibody, to treat steroid-refractory acute graft-versus-host disease. Biol. Blood Marrow Transplant 2005. 11: 465-471.
56. Tedesco-Silva, H., Mourad, G., Kahan, B. D., Boira, J. G., Weimar, W., Mulgaonkar, S., Nashan, B. et al., FTY720, a novel immunomodulator: Efficacy and safety results from the first phase 2A study in de novo renal transplantation. Transplantation 2005. 79: 1553-1560.
57. Kim, J. Y., Lim, S. W., Li, C., Kim, J. S., Ahn, K. O., Yang, H. J., Choi, B. S. et al., Effect of FTY720 on chronic cyclosporine nephropathy in rats. Transplantation 2005. 80: 1323-1330.
58. + progenitor cells. Blood 2004. 103: 4478-4486.
59. Wall, D. A., Hamberg, S. D., Reynolds, D. S., Burakoff, S. J., Abbas, A. K. and Ferrara, J. L., Immunodeficiency in graft-versus-host disease. I. Mechanism of immune suppression. J. Immunol. 1988. 140: 2970-2976.
60. Cooke, K. R., Kobzik, L., Martin, T. R., Brewer, J., Delmonte, J., Jr., Crawford, J. M. and Ferrara, J. L., An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation: I. The roles of minor H antigens and endotoxin. Blood 1996. 88: 3230-3239.
61. + T-cell-dependent mechanism. Blood 2006. 107: 404-409.
62. Seery, J. P., Cattell, V. and Watt, F. M., Cutting edge: Amelioration of kidney disease in a transgenic mouse model of lupus nephritis by administration of the caspase inhibitor carbobenzoxy-valyl-alanyl-aspar-tyl-(beta-o-methyl)-fluoromethylketone. J. Immunol. 2001. 167: 2452-2455.
63. Hashimoto, D., Asakura, S., Miyake, S., Yamamura, T., Van Kaer, L., Liu, C., Tanimoto, M. and Teshima, T., Stimulation of host NKT cells by synthetic glycolipid regulates acute graft-versus-host disease by inducing Th2 polarization of donor T cells. J. Immunol. 2005. 174: 551-556.